The development of POLYTECH and our implants

POLYTECH is founded in Dieburg, Germany, initially focusing on the distribution of medical products for conservative orthopedic treatment and compression garments for burn patients.

The US medical device manufacturer Cooper Surgical and its affiliates Aesthetech and Natural Y, commission POLYTECH to investigate expanding into the German market for breast implants.
POLYTECH starts selling breast implants in Germany.

POLYTECH expands its product portfolio with calf implants and gluteal (buttock) implants. 

POLYTECH expands cooperation with distribution partners, extending its distribution footprint throughout Europe. The company broadens its marketing and sales activities.

Since 1995, POLYTECH products have been allowed to bear the CE mark.

POLYTECH introduces the implant passport. Given to each patient, the passport contains the implants essential information and unique identifiers.

In 2003, POLYTECH is the first company in the world to receive the Class III certification for breast implants.

POLYTECH introduces its unique implant warranty programme “IMPLANTS OF EXCELLENCE”, developed to increase patient satisfaction and boost confidence when choosing POLYTECH implants.

 All production operations, including shell manufacturing and implant filling, are relocated to Dieburg, Germany. 
The company name is now POLYTECH Health & Aesthetics GmbH.

A distribution network is established in the Asia-Pacific Region, first in Australia, New Zealand, Vietnam and Malaysia. 

POLYTECH celebrates its 25th anniversary.
The distribution structure in Latin America is expanded, the company begins preparations for market entry to China.

The existing production facilities are modernised and preparations are made for a sustainable expansion of capacity. 

The existing production capacity is extended by 50%.
POLYTECH increases its distribution network in the EMEA and in Central America regions.

POLYTECH strengthens its international sales management team with dedicated positions for Latin America and Asia Pacific. The German sales and customer service teams are expanded.

POLYTECH expands its production site in Dieburg. The headquarters team is broadened with new positions in production, quality assurance and control.
Mr. Wolfgang Steimel is appointed as POLYTECH’s CEO.

Deutsche Beteiligungs AG (DBAG) acquires a majority stake in POLYTECH as part of a management buyout. The new company owners set the course for future growth and profitability.
POLYTECH receives approval for sales of breast implants in China.
The first POLYTECH long term study on Microthane^® "The Modern Polyurethane Coated Implants in Breast Augmentation" is published. 

The expansion of the production facilities in Dieburg is completed and operations start in the new clean rooms.
A clinical study on an innovative silk protein coating for implant surfaces, which was developed together with the company AMSilk, is prepared.
A long-term study on the tolerability of polyurethane implants in breast reconstruction is published, followed by a study on the compatibility of our implants in breast augmentation.

POLYTECH acquires G&G Biotechnology and thereby acquires the rights to B-Lite^® lightweight breast implants. B-Lite^® implants were manufactured by POLYTECH from the very beginning, and the company was involved in the product development.
POLYTECH announces a new company branding, representing its leadership and position, combining ‘Made in Germany’ quality and meaningful innovation.

POLYTECH implements interim solution for expanding its headquarters and facilitating growth, with additional office space in Rödermark, Germany, relocating its management, customer service and marketing, and enabling additional space for production and quality assurance in its production facility in Dieburg.

POLYTECH expands its IMPLANTS OF EXCELLENCE warranty programme, offering patients who register even more benefits than before.

POLYTECH celebrates its 35th anniversary. 
POLYTECH expands its product portfolio with an exclusive distribution agreement for LipoGrafter^®, an all-in-one closed fat grafting system.

POLYTECH is a global leader in Breast Aesthetics, with a footprint in over 80 countries. 
The company reinforces its commitment to surgeons’ education with its most comprehensive educational programme to date, and with its unique POLYTECH Connect Academy and App for optimising engagement with an online education and knowledge center.

In December 2023 Mr. Wolfgang Steimel, CEO since 2015, retires.

In February 2024 Prof. Dr. Karsten Hemmrich is Appointed as CEO of POLYTECH Health & Aesthetics.
In May 2024 Dr. Markus Neuhauser is Appointed as CFO of POLYTECH Health & Aesthetics.